Multi-omics analysis of bone marrow mesenchymal stem cell differentiation differences in osteoporosis

Osteoporosis is a systemic skeletal disease characterized by low bone mass and degradation of bone tissue microarchitecture, leading to enhanced bone fragility and increased fracture risk. However, the pathogenesis of osteoporosis is unclear. Our results showed that BMSCs dervied from ovariectomized rats had a higher capacity for osteogenesis and lipogenic differentiation compared to the control group. In the meantime, we identified a total of 205 differentially expressed proteins and 2294 differentially expressed genes in BMSCs isolated from ovariectomized rats by proteomics analysis and transcriptome sequencing, respectively. These differentially expressed proteins and genes were mainly involved in ECM-receptor interaction signaling pathway. We speculate that BMSCs derived from ovariectomized rats have a higher potential for bone formation because expression of ECM collagen or genes encoding collagen in the bone ECM in BMSCs isolated from ovariectomized rats are increased compared with that from control group, which provided the prerequisite for the increased bone turnover effect. To conclusion, our results may provid new ideas for further research on the pathogenesis of osteoporosis.

Automated summary

Osteoporosis is characterized by low bone mass and degradation of bone tissue microarchitecture, leading to increased bone fragility and fracture risk. Our study found that BMSCs from ovariectomized rats had higher osteogenic and lipogenic differentiation capacity compared to the control group. Proteomics and transcriptome analysis showed differential expression of proteins and genes mainly involved in ECM-receptor interaction signaling pathway. These findings provide new insights for further research on the pathogenesis of osteoporosis.